Immunocore Holdings PLC IMCR:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/10/24 EDT
58.95UNCH (UNCH)
Volume
4,406
Close
58.95quote price arrow down-0.90 (-1.50%)
Volume
331,156
52 week range
42.21 - 76.98
Loading...
  • Open59.86
  • Day High60.25
  • Day Low58.51
  • Prev Close59.85
  • 52 Week High76.98
  • 52 Week High Date02/01/24
  • 52 Week Low42.21
  • 52 Week Low Date10/30/23

Key Stats

  • Market Cap2.946B
  • Shares Out49.98M
  • 10 Day Average Volume0.41M
  • Dividend-
  • Dividend Yield-
  • Beta1.04
  • YTD % Change-13.71

KEY STATS

  • Open59.86
  • Day High60.25
  • Day Low58.51
  • Prev Close59.85
  • 52 Week High76.98
  • 52 Week High Date02/01/24
  • 52 Week Low42.21
  • 52 Week Low Date10/30/23
  • Market Cap2.946B
  • Shares Out49.98M
  • 10 Day Average Volume0.41M
  • Dividend-
  • Dividend Yield-
  • Beta1.04
  • YTD % Change-13.71

RATIOS/PROFITABILITY

  • EPS (TTM)-1.32
  • P/E (TTM)-44.54
  • Fwd P/E (NTM)-33.53
  • EBITDA (TTM)-55.559M
  • ROE (TTM)-15.62%
  • Revenue (TTM)249.428M
  • Gross Margin (TTM)99.58%
  • Net Margin (TTM)-22.17%
  • Debt To Equity (MRQ)13.02%

EVENTS

  • Earnings Date08/08/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Immunocore Holdings PLC

 

Profile

MORE
Immunocore Holdings plc is a United Kingdom-based commercial-stage biotechnology company. The Company is engaged in the development of TCR bispecific immunotherapies, ImmTAX, which immunes mobilizing monoclonal TCRs Against X disease, designed to treat a range of diseases, including cancer, autoimmune and infectious disease. The Company has a clinical-stage pipeline of wholly owned and partnered programs across three different therapeutic areas: oncology, infectious diseases...
John Bell
Independent Chairman of the Board
Bahija Jallal Ph.D.
Chief Executive Officer, Director
Brian Di Donato
Chief Financial Officer, Head of Strategy
Address
90 Park Drive, Milton Park, Abingdon
Abingdon
OX14 4RY
United Kingdom

Top Peers

SYMBOLLASTCHG%CHG
MOR
MorphoSys AG
18.00+0.13+0.73%
TGTX
TG Therapeutics Inc
16.62-0.30-1.77%
TWST
Twist Bioscience Corp
42.37-0.83-1.92%
DNLI
Denali Therapeutics Inc
18.31-0.36-1.93%
AXSM
Axsome Therapeutics Inc
72.50-1.18-1.60%